SYNCHRONOUS DIAGNOSIS OF TESTICULAR AND THYROID CANCER IN A YOUNG MALE.


Journal

Experimental oncology
ISSN: 2312-8852
Titre abrégé: Exp Oncol
Pays: Ukraine
ID NLM: 101230541

Informations de publication

Date de publication:
11 10 2023
Historique:
received: 11 10 2023
medline: 1 11 2023
pubmed: 12 10 2023
entrez: 12 10 2023
Statut: epublish

Résumé

Testicular cancer is the most common neoplasm in young males. The early diagnosis and the appropriate treatment make it a curable malignancy in over 90% of the patients, but 6% of the patients with testicular cancer develop a second, mostly treatment-related, malignancy in another primary site many years after the first diagnosis. The simultaneous appearance of a testicular tumor with another primary neoplasm is rarely described in the literature. Here is presented an interesting case of a coexisting non-seminomatous germ cell testicular tumor with a papillary thyroid carcinoma, which was detected early during post-treatment restaging of the testicular tumor. The synchronous presence of these two neoplasms might indicate a probable common pathogenetic background. As treatment-related oncogenesis is highly improbable in this case and the common environmental factors are not known yet, the interest is focused on genetic predisposition. Recent discoveries in molecular genetics show that the two neoplasms share common genetic alterations in the RAS and BRAF genes, which affect the significant signaling pathways. Interestingly, BRAF-V600E was positive in both primary malignancies in our individual.

Identifiants

pubmed: 37824765
doi: 10.15407/exp-oncology.2023.02.263
doi:

Substances chimiques

Proto-Oncogene Proteins B-raf EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-268

Auteurs

N Tsoukalas (N)

401 General Military Hospital, Athens 11524, Greece.

M Kiakou (M)

401 General Military Hospital, Athens 11524, Greece.

M Tolia (M)

Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

M Galanopoulos (M)

401 General Military Hospital, Athens 11524, Greece.

K Tsapakidis (K)

Department of Radiotherapy-Radiation Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

E Arvanitou (E)

401 General Military Hospital, Athens 11524, Greece.

N Charalambakis (N)

Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece.

V Tountziaris (V)

1st Urological Department, Aristotle University of Thessaloniki, Greece.

M Nikolaou (M)

1st Oncology Department, Anti-cancer Hospital "Sant Savvas", Athens, Greece.

Ch Christofyllakis (C)

401 General Military Hospital, Athens 11524, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH